Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Aug 6:100:102228.
doi: 10.1016/j.molmet.2025.102228. Online ahead of print.

Three-dimensional network of creatine metabolism: From intracellular energy shuttle to systemic metabolic regulatory switch

Affiliations
Review

Three-dimensional network of creatine metabolism: From intracellular energy shuttle to systemic metabolic regulatory switch

Yuhui Su. Mol Metab. .

Abstract

Background: Creatine serves as an intracellular shuttle for high-energy phosphate bonds, enabling rapid ATP transfer from energy-producing to energy-consuming cellular compartments. In skeletal muscle, creatine coordinates energy distribution among mitochondrial oxidative phosphorylation, glycolysis, and the phosphagen system. Consequently, creatine supplementation acutely enhances muscular performance and is widely utilized as an ergogenic aid in power-based sports. Recent studies demonstrate that enhanced creatine metabolism in adipose tissue promotes brown adipocyte renewal and boosts energy expenditure in cold environments or sedentary conditions, thereby improving overall systemic metabolism. Beyond its traditional role as an exercise supplement, the creatine metabolic network has emerged as a promising therapeutic target for metabolic disorders.

Scope of review: This review begins by revisiting the history and latest advancements in creatine research, and ultimately proposes three dimensions for the current explanation of creatine metabolism: (1) subcellular energy transport; (2) muscle-fat metabolic axis; (3) systemic energy sensing and metabolic reprogramming.

Major conclusions: The creatine cycle enables directed energy flow through mitochondrial supercomplexes (VDAC/ANT-CK) and resets systemic metabolism via subcellular energy tunnels and inter-organ interactions. Creatine kinase (CK) condensates, through liquid-liquid phase separation, can rapidly meet energy demands during exercise. Therefore, targeting the dynamics of the CK phase may be promising for enhancing athletic performance and improving metabolic diseases.

Keywords: Creatine; Energy metabolism; Exercise; Metabolic diseases; Phase separation; Thermogenesis.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Figure 1
Figure 1
The BLSA Metabolic Axis Model of Creatine. Creatine synthesized by the liver is distributed to various tissues and organs through the bloodstream, entering the intracellular creatine cycle. The creatine cycle in skeletal muscle is coupled with ATP synthesis, consuming energy in the form of work output (exercise); the creatine cycle in adipose tissue is coupled with thermogenesis, consuming energy in the form of heat. The creatine cycle in the brain can sense the system energy metabolic status and subsequently regulate the energy expenditure relationship between tissues and organs through neural and endocrine mechanisms. This model defines creatine as the core regulator of systemic energy distribution, enabling diverse energy allocation through creatine cycles in different tissues. This model not only reveals how creatine coordinates energy distribution among different tissues but also suggests that regulating creatine metabolism could be a new strategy for treating metabolic diseases. By controlling creatine cycle, it may be possible to achieve fine-tuned management of energy metabolism, thereby reversing pathological processes of obesity, diabetes, and other metabolic diseases.
Figure 2
Figure 2
Putative topology of the VDAC/ANT-CK supramolecular machine. The cubic homooligomer umtCK (red surface) and its direct interaction partner VDAC (yellow surface) are embedded in phospholipid cardiolipin (CL, white surface) within the mitochondrial outer membrane (MOM) and inner membrane (MIM). ANT (magenta surface) is located near this complex in the MIM, and functional data and co-purification experiments indicate a close proximity between them, suggesting they reside within the same MIM phosphatidyl carnitine patch. Note that this figure only shows the interaction of one CL molecule and one VDAC dimer with one dimer of the umtCK octamer; however, each mtCK dimer may participate in such interactions, including additional interactions with other anionic phospholipids in the MOM. Additionally, VDAC and ANT likely form dimers (as shown) or higher-order oligomers in vivo, and this figure only depicts the crystal structure of the dimer (Schlattner et al. ,2018). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Figure 3
Figure 3
Phase separation of CK condensates. This spatiotemporal mechanism allows creatine kinase CK to form dynamic condensates, temporarily coupling CK kinase with its substrate ADP, creating localized ‘energy reaction containers’. Molecular dynamics simulations show that when PCr concentration exceeds 25 mM, CK undergoes liquid–liquid phase separation and assembles into membrane-associated condensates within mitochondrial inner membrane microdomains rich in ANT and CK-MT. These protein-lipid platforms composed of phosphatidylcholine, phosphatidylethanolamine, and cardiolipin rapidly increase local ATP regeneration through substrate channels. Given the significant reliance of this process on physical phase transitions, it is markedly faster than complex biochemical reactions, making it more suitable for the sudden energy demands encountered during exercise.

Similar articles

  • Prescription of Controlled Substances: Benefits and Risks.
    Preuss CV, Kalava A, King KC. Preuss CV, et al. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
  • Management of urinary stones by experts in stone disease (ESD 2025).
    Papatsoris A, Geavlete B, Radavoi GD, Alameedee M, Almusafer M, Ather MH, Budia A, Cumpanas AA, Kiremi MC, Dellis A, Elhowairis M, Galán-Llopis JA, Geavlete P, Guimerà Garcia J, Isern B, Jinga V, Lopez JM, Mainez JA, Mitsogiannis I, Mora Christian J, Moussa M, Multescu R, Oguz Acar Y, Petkova K, Piñero A, Popov E, Ramos Cebrian M, Rascu S, Siener R, Sountoulides P, Stamatelou K, Syed J, Trinchieri A. Papatsoris A, et al. Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
  • The Black Book of Psychotropic Dosing and Monitoring.
    DeBattista C, Schatzberg AF. DeBattista C, et al. Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
  • The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism: a systematic review.
    Oudman I, Clark JF, Brewster LM. Oudman I, et al. PLoS One. 2013;8(1):e52879. doi: 10.1371/journal.pone.0052879. Epub 2013 Jan 9. PLoS One. 2013. PMID: 23326362 Free PMC article.
  • Short-Term Memory Impairment.
    Cascella M, Al Khalili Y. Cascella M, et al. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.

References

    1. Forbes S.C., Cordingley D.M., Cornish S.M., Gualano B., Roschel H., Ostojic S.M., et al. Effects of creatine supplementation on brain function and health. Nutrients. 2022;14(5):84881941. - PMC - PubMed
    1. Chouchani E.T., Kazak L., Spiegelman B.M. New advances in adaptive thermogenesis: UCP1 and beyond. Cell Metab. 2019;29(1):27–37. - PubMed
    1. Kazak L., Rahbani J.F., Samborska B., Lu G.Z., Jedrychowski M.P., Lajoie M., et al. Ablation of adipocyte creatine transport impairs thermogenesis and causes diet-induced obesity. Nat Metab. 2019;1(3):360–370. - PMC - PubMed
    1. Rahbani J.F., Bunk J., Lagarde D., Samborska B., Roesler A., Xiao H., et al. Parallel control of cold-triggered adipocyte thermogenesis by UCP1 and CKB. Cell Metab. 2024;36(3):526–540.e7. - PubMed
    1. Rahbani J.F., Roesler A., Hussain M.F., Samborska B., Dykstra C.B., Tsai L., et al. Creatine kinase B controls futile creatine cycling in thermogenic fat. Nature. 2021;590(7846):480–485. - PMC - PubMed